nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Alzheimer's disease	0.276	1	CbGaD
Mivacurium—CHRNA1—Galantamine—Alzheimer's disease	0.128	0.21	CbGbCtD
Mivacurium—CHRND—Galantamine—Alzheimer's disease	0.128	0.21	CbGbCtD
Mivacurium—CHRNB1—Galantamine—Alzheimer's disease	0.128	0.21	CbGbCtD
Mivacurium—CHRNA2—Galantamine—Alzheimer's disease	0.0944	0.155	CbGbCtD
Mivacurium—BCHE—Rivastigmine—Alzheimer's disease	0.0859	0.141	CbGbCtD
Mivacurium—BCHE—Galantamine—Alzheimer's disease	0.0442	0.0727	CbGbCtD
Mivacurium—Wheezing—Donepezil—Alzheimer's disease	0.00125	0.041	CcSEcCtD
Mivacurium—Doxacurium chloride—BCHE—Alzheimer's disease	0.00109	1	CrCbGaD
Mivacurium—Phlebitis—Memantine—Alzheimer's disease	0.000984	0.0323	CcSEcCtD
Mivacurium—Phlebitis—Rivastigmine—Alzheimer's disease	0.000962	0.0316	CcSEcCtD
Mivacurium—Bradycardia—Galantamine—Alzheimer's disease	0.000848	0.0279	CcSEcCtD
Mivacurium—CHRNA2—forebrain—Alzheimer's disease	0.000848	0.104	CbGeAlD
Mivacurium—Cardiac disorder—Galantamine—Alzheimer's disease	0.000773	0.0254	CcSEcCtD
Mivacurium—Flushing—Galantamine—Alzheimer's disease	0.000773	0.0254	CcSEcCtD
Mivacurium—Angiopathy—Galantamine—Alzheimer's disease	0.000756	0.0248	CcSEcCtD
Mivacurium—Immune system disorder—Galantamine—Alzheimer's disease	0.000753	0.0247	CcSEcCtD
Mivacurium—Arrhythmia—Galantamine—Alzheimer's disease	0.000744	0.0244	CcSEcCtD
Mivacurium—Bronchospasm—Memantine—Alzheimer's disease	0.000721	0.0237	CcSEcCtD
Mivacurium—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000705	0.0232	CcSEcCtD
Mivacurium—Muscle spasms—Galantamine—Alzheimer's disease	0.000697	0.0229	CcSEcCtD
Mivacurium—Bradycardia—Donepezil—Alzheimer's disease	0.000657	0.0216	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000613	0.0201	CcSEcCtD
Mivacurium—Bradycardia—Memantine—Alzheimer's disease	0.000597	0.0196	CcSEcCtD
Mivacurium—Bradycardia—Rivastigmine—Alzheimer's disease	0.000584	0.0192	CcSEcCtD
Mivacurium—Tachycardia—Galantamine—Alzheimer's disease	0.000578	0.019	CcSEcCtD
Mivacurium—Arrhythmia—Donepezil—Alzheimer's disease	0.000577	0.0189	CcSEcCtD
Mivacurium—Skin disorder—Galantamine—Alzheimer's disease	0.000575	0.0189	CcSEcCtD
Mivacurium—Erythema—Donepezil—Alzheimer's disease	0.000562	0.0185	CcSEcCtD
Mivacurium—Hypotension—Galantamine—Alzheimer's disease	0.000553	0.0182	CcSEcCtD
Mivacurium—Flushing—Memantine—Alzheimer's disease	0.000544	0.0179	CcSEcCtD
Mivacurium—Cardiac disorder—Memantine—Alzheimer's disease	0.000544	0.0179	CcSEcCtD
Mivacurium—Muscle spasms—Donepezil—Alzheimer's disease	0.00054	0.0178	CcSEcCtD
Mivacurium—Flushing—Rivastigmine—Alzheimer's disease	0.000532	0.0175	CcSEcCtD
Mivacurium—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000532	0.0175	CcSEcCtD
Mivacurium—Angiopathy—Memantine—Alzheimer's disease	0.000532	0.0175	CcSEcCtD
Mivacurium—Immune system disorder—Memantine—Alzheimer's disease	0.00053	0.0174	CcSEcCtD
Mivacurium—Mediastinal disorder—Memantine—Alzheimer's disease	0.000528	0.0174	CcSEcCtD
Mivacurium—Arrhythmia—Memantine—Alzheimer's disease	0.000524	0.0172	CcSEcCtD
Mivacurium—Angiopathy—Rivastigmine—Alzheimer's disease	0.00052	0.0171	CcSEcCtD
Mivacurium—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000517	0.017	CcSEcCtD
Mivacurium—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000512	0.0168	CcSEcCtD
Mivacurium—CHRM2—forebrain—Alzheimer's disease	0.000505	0.0622	CbGeAlD
Mivacurium—Erythema—Rivastigmine—Alzheimer's disease	0.000499	0.0164	CcSEcCtD
Mivacurium—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00048	0.0158	CcSEcCtD
Mivacurium—CHRM2—telencephalon—Alzheimer's disease	0.000465	0.0572	CbGeAlD
Mivacurium—CHRNA2—nervous system—Alzheimer's disease	0.00046	0.0567	CbGeAlD
Mivacurium—CHRNA2—central nervous system—Alzheimer's disease	0.000443	0.0545	CbGeAlD
Mivacurium—CHRNA2—cerebellum—Alzheimer's disease	0.000433	0.0533	CbGeAlD
Mivacurium—Hypotension—Donepezil—Alzheimer's disease	0.000429	0.0141	CcSEcCtD
Mivacurium—CHRNA1—brain—Alzheimer's disease	0.000424	0.0522	CbGeAlD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000422	0.0139	CcSEcCtD
Mivacurium—CHRM3—forebrain—Alzheimer's disease	0.000412	0.0507	CbGeAlD
Mivacurium—Tachycardia—Memantine—Alzheimer's disease	0.000407	0.0134	CcSEcCtD
Mivacurium—Skin disorder—Memantine—Alzheimer's disease	0.000405	0.0133	CcSEcCtD
Mivacurium—CHRNB1—cerebellum—Alzheimer's disease	0.000403	0.0496	CbGeAlD
Mivacurium—Tachycardia—Rivastigmine—Alzheimer's disease	0.000398	0.0131	CcSEcCtD
Mivacurium—Skin disorder—Rivastigmine—Alzheimer's disease	0.000396	0.013	CcSEcCtD
Mivacurium—Dizziness—Galantamine—Alzheimer's disease	0.000391	0.0129	CcSEcCtD
Mivacurium—Hypotension—Memantine—Alzheimer's disease	0.000389	0.0128	CcSEcCtD
Mivacurium—Hypotension—Rivastigmine—Alzheimer's disease	0.000381	0.0125	CcSEcCtD
Mivacurium—CHRM3—telencephalon—Alzheimer's disease	0.000379	0.0466	CbGeAlD
Mivacurium—Rash—Galantamine—Alzheimer's disease	0.000373	0.0123	CcSEcCtD
Mivacurium—Dermatitis—Galantamine—Alzheimer's disease	0.000373	0.0122	CcSEcCtD
Mivacurium—Urticaria—Donepezil—Alzheimer's disease	0.000364	0.012	CcSEcCtD
Mivacurium—CHRNA2—brain—Alzheimer's disease	0.000352	0.0433	CbGeAlD
Mivacurium—BCHE—forebrain—Alzheimer's disease	0.000336	0.0414	CbGeAlD
Mivacurium—Urticaria—Memantine—Alzheimer's disease	0.000331	0.0109	CcSEcCtD
Mivacurium—CHRNB1—brain—Alzheimer's disease	0.000327	0.0403	CbGeAlD
Mivacurium—Urticaria—Rivastigmine—Alzheimer's disease	0.000324	0.0106	CcSEcCtD
Mivacurium—BCHE—telencephalon—Alzheimer's disease	0.000309	0.0381	CbGeAlD
Mivacurium—Dizziness—Donepezil—Alzheimer's disease	0.000303	0.00996	CcSEcCtD
Mivacurium—Rash—Donepezil—Alzheimer's disease	0.000289	0.0095	CcSEcCtD
Mivacurium—Dermatitis—Donepezil—Alzheimer's disease	0.000289	0.00949	CcSEcCtD
Mivacurium—Dizziness—Memantine—Alzheimer's disease	0.000275	0.00905	CcSEcCtD
Mivacurium—CHRM2—nervous system—Alzheimer's disease	0.000274	0.0338	CbGeAlD
Mivacurium—Dizziness—Rivastigmine—Alzheimer's disease	0.000269	0.00885	CcSEcCtD
Mivacurium—CHRM2—central nervous system—Alzheimer's disease	0.000264	0.0325	CbGeAlD
Mivacurium—Rash—Memantine—Alzheimer's disease	0.000263	0.00863	CcSEcCtD
Mivacurium—Dermatitis—Memantine—Alzheimer's disease	0.000262	0.00862	CcSEcCtD
Mivacurium—Rash—Rivastigmine—Alzheimer's disease	0.000257	0.00844	CcSEcCtD
Mivacurium—Dermatitis—Rivastigmine—Alzheimer's disease	0.000257	0.00843	CcSEcCtD
Mivacurium—CHRM3—nervous system—Alzheimer's disease	0.000224	0.0275	CbGeAlD
Mivacurium—CHRM3—central nervous system—Alzheimer's disease	0.000215	0.0265	CbGeAlD
Mivacurium—CHRM2—brain—Alzheimer's disease	0.00021	0.0258	CbGeAlD
Mivacurium—BCHE—nervous system—Alzheimer's disease	0.000182	0.0225	CbGeAlD
Mivacurium—BCHE—central nervous system—Alzheimer's disease	0.000176	0.0216	CbGeAlD
Mivacurium—BCHE—cerebellum—Alzheimer's disease	0.000172	0.0211	CbGeAlD
Mivacurium—CHRM3—brain—Alzheimer's disease	0.000171	0.021	CbGeAlD
Mivacurium—BCHE—brain—Alzheimer's disease	0.000139	0.0172	CbGeAlD
Mivacurium—CHRM3—Signaling by GPCR—GAL—Alzheimer's disease	1.85e-05	0.000243	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	1.83e-05	0.00024	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.83e-05	0.00024	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TTR—Alzheimer's disease	1.81e-05	0.000237	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	1.8e-05	0.000235	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	1.79e-05	0.000234	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	1.78e-05	0.000233	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.78e-05	0.000233	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	1.71e-05	0.000224	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—TPI1—Alzheimer's disease	1.68e-05	0.000221	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CHAT—Alzheimer's disease	1.68e-05	0.000221	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MAOB—Alzheimer's disease	1.61e-05	0.000211	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—NPY—Alzheimer's disease	1.6e-05	0.00021	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	1.6e-05	0.00021	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CCR5—Alzheimer's disease	1.59e-05	0.000209	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—IAPP—Alzheimer's disease	1.59e-05	0.000209	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	1.59e-05	0.000208	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	1.59e-05	0.000208	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	1.58e-05	0.000207	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PYY—Alzheimer's disease	1.58e-05	0.000207	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	1.58e-05	0.000207	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	1.56e-05	0.000205	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—HTR2A—Alzheimer's disease	1.56e-05	0.000204	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GAPDH—Alzheimer's disease	1.55e-05	0.000204	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CRH—Alzheimer's disease	1.55e-05	0.000203	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	1.55e-05	0.000202	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.54e-05	0.000201	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	1.53e-05	0.000201	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.52e-05	0.0002	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.52e-05	0.000199	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—A2M—Alzheimer's disease	1.5e-05	0.000197	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—NPS—Alzheimer's disease	1.47e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—NPY—Alzheimer's disease	1.46e-05	0.000191	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	1.45e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IAPP—Alzheimer's disease	1.45e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	1.44e-05	0.000189	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	1.43e-05	0.000188	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CRH—Alzheimer's disease	1.4e-05	0.000184	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—GAB2—Alzheimer's disease	1.4e-05	0.000183	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—SST—Alzheimer's disease	1.4e-05	0.000183	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	1.39e-05	0.000182	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.38e-05	0.000181	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	1.38e-05	0.000181	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDK5—Alzheimer's disease	1.37e-05	0.000179	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—F2—Alzheimer's disease	1.37e-05	0.000179	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—APP—Alzheimer's disease	1.36e-05	0.000179	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	1.36e-05	0.000178	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	1.35e-05	0.000177	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	1.35e-05	0.000177	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.34e-05	0.000175	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—NPS—Alzheimer's disease	1.33e-05	0.000174	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	1.33e-05	0.000174	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.32e-05	0.000174	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	1.32e-05	0.000173	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR6—Alzheimer's disease	1.32e-05	0.000173	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.31e-05	0.000172	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ACHE—Alzheimer's disease	1.31e-05	0.000171	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	1.31e-05	0.000171	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—TPI1—Alzheimer's disease	1.29e-05	0.00017	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CHAT—Alzheimer's disease	1.29e-05	0.00017	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.29e-05	0.000169	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.29e-05	0.000168	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.27e-05	0.000167	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—GAB2—Alzheimer's disease	1.27e-05	0.000166	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—SST—Alzheimer's disease	1.27e-05	0.000166	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	1.26e-05	0.000165	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	1.26e-05	0.000165	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.25e-05	0.000164	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MAOB—Alzheimer's disease	1.24e-05	0.000163	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—APP—Alzheimer's disease	1.24e-05	0.000162	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.23e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	1.23e-05	0.000161	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ENO1—Alzheimer's disease	1.22e-05	0.00016	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.22e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CCL2—Alzheimer's disease	1.22e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	1.21e-05	0.000158	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.2e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PSENEN—Alzheimer's disease	1.2e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GAPDH—Alzheimer's disease	1.19e-05	0.000156	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	1.19e-05	0.000155	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APH1A—Alzheimer's disease	1.18e-05	0.000155	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	1.17e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PLCB1—Alzheimer's disease	1.17e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.16e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—A2M—Alzheimer's disease	1.15e-05	0.000151	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NCSTN—Alzheimer's disease	1.15e-05	0.000151	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	1.14e-05	0.000149	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.13e-05	0.000149	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LRP1—Alzheimer's disease	1.12e-05	0.000147	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.12e-05	0.000146	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	1.11e-05	0.000145	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.1e-05	0.000144	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GFAP—Alzheimer's disease	1.09e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GAL—Alzheimer's disease	1.09e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.08e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.08e-05	0.000142	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.07e-05	0.000141	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.05e-05	0.000138	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.04e-05	0.000136	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ACHE—Alzheimer's disease	1e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—INPP5D—Alzheimer's disease	9.92e-06	0.00013	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—A2M—Alzheimer's disease	9.65e-06	0.000126	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	9.6e-06	0.000126	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	9.55e-06	0.000125	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.51e-06	0.000125	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.42e-06	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ENO1—Alzheimer's disease	9.4e-06	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS1—Alzheimer's disease	9.4e-06	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	9.34e-06	0.000122	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	9.25e-06	0.000121	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	9.22e-06	0.000121	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	9.01e-06	0.000118	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	8.96e-06	0.000117	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	8.92e-06	0.000117	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—HMOX1—Alzheimer's disease	8.92e-06	0.000117	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.82e-06	0.000116	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—BCHE—Alzheimer's disease	8.74e-06	0.000115	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.73e-06	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	8.64e-06	0.000113	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	8.6e-06	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	8.55e-06	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	8.54e-06	0.000112	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	8.51e-06	0.000112	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	8.46e-06	0.000111	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	8.29e-06	0.000109	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PLCB1—Alzheimer's disease	8.25e-06	0.000108	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	8.21e-06	0.000108	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	8.18e-06	0.000107	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—LPL—Alzheimer's disease	8.16e-06	0.000107	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	8.1e-06	0.000106	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	8.01e-06	0.000105	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ABCA1—Alzheimer's disease	8e-06	0.000105	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	7.93e-06	0.000104	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	7.86e-06	0.000103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	7.82e-06	0.000103	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	7.79e-06	0.000102	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	7.75e-06	0.000102	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	7.73e-06	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	7.71e-06	0.000101	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	7.66e-06	0.0001	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	7.64e-06	0.0001	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SST—Alzheimer's disease	7.5e-06	9.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	7.5e-06	9.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	7.5e-06	9.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	7.47e-06	9.79e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	7.44e-06	9.74e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	7.43e-06	9.73e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SST—Alzheimer's disease	7.43e-06	9.73e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	7.43e-06	9.73e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	7.4e-06	9.69e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	7.36e-06	9.65e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MTHFR—Alzheimer's disease	7.35e-06	9.63e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APP—Alzheimer's disease	7.31e-06	9.58e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APP—Alzheimer's disease	7.24e-06	9.48e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	7.02e-06	9.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	6.95e-06	9.11e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	6.9e-06	9.04e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	6.89e-06	9.03e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CALM1—Alzheimer's disease	6.86e-06	8.99e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMOX1—Alzheimer's disease	6.86e-06	8.99e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—Alzheimer's disease	6.84e-06	8.96e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	6.83e-06	8.95e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CAV1—Alzheimer's disease	6.78e-06	8.88e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	6.44e-06	8.43e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	6.4e-06	8.38e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	6.37e-06	8.35e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	6.33e-06	8.3e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	6.29e-06	8.24e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LPL—Alzheimer's disease	6.27e-06	8.22e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	6.26e-06	8.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	6.23e-06	8.16e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	6.2e-06	8.12e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—Alzheimer's disease	5.96e-06	7.81e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	5.94e-06	7.79e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	5.89e-06	7.71e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—INS—Alzheimer's disease	5.84e-06	7.66e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	5.66e-06	7.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—Alzheimer's disease	5.65e-06	7.4e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	5.6e-06	7.34e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	5.47e-06	7.17e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	5.42e-06	7.1e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CALM1—Alzheimer's disease	5.28e-06	6.92e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—Alzheimer's disease	5.26e-06	6.89e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	5.25e-06	6.87e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAV1—Alzheimer's disease	5.21e-06	6.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	5.2e-06	6.81e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	5.2e-06	6.81e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	5.15e-06	6.75e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NOS3—Alzheimer's disease	5.12e-06	6.71e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	5.1e-06	6.68e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	5.05e-06	6.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	4.97e-06	6.51e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	4.92e-06	6.45e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	4.83e-06	6.33e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	4.79e-06	6.27e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	4.73e-06	6.2e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—Alzheimer's disease	4.69e-06	6.14e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	4.68e-06	6.14e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—Alzheimer's disease	4.58e-06	6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—INS—Alzheimer's disease	4.49e-06	5.89e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	4.41e-06	5.78e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	4.4e-06	5.76e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	4.4e-06	5.76e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	4.37e-06	5.73e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	4.36e-06	5.71e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	4.35e-06	5.71e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	4.35e-06	5.71e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	4.31e-06	5.65e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	4.2e-06	5.5e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	4.16e-06	5.45e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2—Alzheimer's disease	4.15e-06	5.43e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2—Alzheimer's disease	4.11e-06	5.38e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	4.06e-06	5.32e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.02e-06	5.27e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NOS3—Alzheimer's disease	3.94e-06	5.16e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	3.81e-06	4.99e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	3.78e-06	4.95e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	3.77e-06	4.94e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—INS—Alzheimer's disease	3.76e-06	4.92e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	3.74e-06	4.9e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—INS—Alzheimer's disease	3.72e-06	4.87e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	3.7e-06	4.84e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	3.66e-06	4.8e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	3.63e-06	4.76e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—Alzheimer's disease	3.6e-06	4.72e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	3.6e-06	4.71e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	3.29e-06	4.32e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	3.26e-06	4.27e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.82e-06	3.7e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	2.8e-06	3.66e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.8e-06	3.66e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	2.78e-06	3.64e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.77e-06	3.63e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.75e-06	3.61e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	2.57e-06	3.37e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	2.56e-06	3.36e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.55e-06	3.34e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.54e-06	3.33e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	2.37e-06	3.11e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—Alzheimer's disease	2.36e-06	3.09e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.35e-06	3.08e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	2.18e-06	2.85e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.16e-06	2.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.81e-06	2.37e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.79e-06	2.35e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.78e-06	2.33e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.64e-06	2.15e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.63e-06	2.13e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.51e-06	1.98e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-06	1.97e-05	CbGpPWpGaD
